Soluble Receptor for Advanced Glycation End Products (sRAGE) Isoforms Predict Changes in Resting Energy Expenditure in Adults with Obesity during Weight Loss.

Collin J PoppBoyan ZhouMichaele B ManigrassoHuilin LiMargaret CurranLu HuDavid E St-JulesJosé O AlemánSally M VanegasMelanie JayMichael BergmanEran SegalMary A SevickAnn Marie Schmidt

Published in: Current developments in nutrition (2022)

This study demonstrates a novel link between RAGE and energy expenditure in human participants undergoing weight loss.This trial was registered at clinicaltrials.gov as NCT03336411.

Keyphrases

weight loss
bariatric surgery
roux en y gastric bypass
gastric bypass
endothelial cells
weight gain
clinical trial
glycemic control
heart rate
metabolic syndrome
insulin resistance
induced pluripotent stem cells
blood pressure
adipose tissue
physical activity
double blind